- Home
- PBHC vs ANEB Comparison
PBHC vs ANEB Comparison
Compare PBHC & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBHC
- ANEB
- Stock Information
- Founded
- PBHC 1859
- ANEB 2020
- Country
- PBHC United States
- ANEB United States
- Employees
- PBHC N/A
- ANEB N/A
- Industry
- PBHC Major Banks
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- PBHC Finance
- ANEB Health Care
- Exchange
- PBHC Nasdaq
- ANEB Nasdaq
- Market Cap
- PBHC 93.1M
- ANEB 98.6M
- IPO Year
- PBHC N/A
- ANEB 2021
- Fundamental
- Price
- PBHC N/A
- ANEB $2.30
- Analyst Decision
- PBHC
- ANEB Buy
- Analyst Count
- PBHC 0
- ANEB 2
- Target Price
- PBHC N/A
- ANEB $8.00
- AVG Volume (30 Days)
- PBHC 3.4K
- ANEB 104.8K
- Earning Date
- PBHC 10-29-2025
- ANEB 11-12-2025
- Dividend Yield
- PBHC 2.60%
- ANEB N/A
- EPS Growth
- PBHC N/A
- ANEB N/A
- EPS
- PBHC 0.28
- ANEB N/A
- Revenue
- PBHC $39,015,000.00
- ANEB N/A
- Revenue This Year
- PBHC N/A
- ANEB N/A
- Revenue Next Year
- PBHC N/A
- ANEB N/A
- P/E Ratio
- PBHC $54.80
- ANEB N/A
- Revenue Growth
- PBHC N/A
- ANEB N/A
- 52 Week Low
- PBHC $13.55
- ANEB $0.80
- 52 Week High
- PBHC $19.86
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- PBHC N/A
- ANEB 49.32
- Support Level
- PBHC N/A
- ANEB $2.23
- Resistance Level
- PBHC N/A
- ANEB $2.47
- Average True Range (ATR)
- PBHC 0.00
- ANEB 0.10
- MACD
- PBHC 0.00
- ANEB -0.01
- Stochastic Oscillator
- PBHC 0.00
- ANEB 43.23
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.